↓ Skip to main content

Dove Medical Press

Clinical outcomes of long-acting injectable risperidone in patients with schizophrenia: six-month follow-up from the Electronic Schizophrenia Treatment Adherence Registry in Latin America

Overview of attention for article published in Neuropsychiatric Disease and Treatment, December 2010
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (72nd percentile)

Mentioned by

policy
1 policy source
twitter
1 X user

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
43 Mendeley
Title
Clinical outcomes of long-acting injectable risperidone in patients with schizophrenia: six-month follow-up from the Electronic Schizophrenia Treatment Adherence Registry in Latin America
Published in
Neuropsychiatric Disease and Treatment, December 2010
DOI 10.2147/ndt.s15911
Pubmed ID
Authors

Rogelio Apiquian, Rodrigo Córdoba, Mario Louzã

Abstract

Risperidone long-acting injection (RLAI) has been shown to be efficacious, improve compliance, and increase long-term retention rate on therapy. The aim of this work was to determine the effect of RLAI on clinical outcome and hospitalization rate in patients with schizophrenia or schizoaffective disorder enrolled in the electronic Schizophrenia Treatment Adherence Registry in Latin America.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Brazil 1 2%
Unknown 41 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 21%
Student > Master 7 16%
Student > Ph. D. Student 6 14%
Student > Bachelor 5 12%
Other 3 7%
Other 7 16%
Unknown 6 14%
Readers by discipline Count As %
Medicine and Dentistry 15 35%
Psychology 7 16%
Nursing and Health Professions 3 7%
Economics, Econometrics and Finance 3 7%
Neuroscience 2 5%
Other 5 12%
Unknown 8 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 July 2014.
All research outputs
#7,355,930
of 25,374,647 outputs
Outputs from Neuropsychiatric Disease and Treatment
#948
of 3,132 outputs
Outputs of similar age
#49,471
of 190,761 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#5
of 7 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 3,132 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 190,761 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.